Predictive metabolite signatures for risk of progression to active TB from QuantiFERON supernatants of household contacts of TB patients
Authors:
- Evangeline Ann DanielEDEvangeline Ann Daniel
- Shubham UpadhyaySUShubham Upadhyay
- Sathyamurthi PattabiramanSPSathyamurthi Pattabiraman
- Vandana KulkarniVKVandana Kulkarni
- Rajesh KaryakarteRKRajesh Karyakarte
- Sanjay GaikwadSGSanjay Gaikwad
- Mandar ParadkarMPMandar Paradkar
- Shri Vijay Bala Yogendra ShivakumarSSShri Vijay Bala Yogendra Shivakumar
- Vidya MaveVMVidya Mave
Open Access
- 22 December 2024
- journal article
- research article
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 14 (1) , 2437242
Abstract
The identification of individuals with the greatest risk of progression to active tuberculosis (TB) disease from the huge reservoir of Mycobacterium tuberculosis (Mtb) infected individuals continues to remain an arduous ascent in the global effort to control TB. In a two-year prospective study, we analysed metabolic profiles in the unstimulated and TB antigen stimulated QuantiFERON supernatants of 14 healthy household contacts (HHCs) who progressed to TB disease (Progressors) and 14 HHCs who remained healthy (Non-Progressors). We identified 21 significantly dysregulated metabolites in the TB antigen-stimulated QuantiFERON supernatants of Progressors, of which the combination of Malic acid and N-Arachidonoylglycine had maximum AUC of 0.99. Eighteen significantly dysregulated metabolites were identified in the unstimulated QuantiFERON supernatants of Progressors, among which the combination of Orotic acid and the phosphatidylcholines PC (O-34:1), PC (O-18:1(9Z)/16:0), PC (O-18:1(11Z)/16:0) had the maximum AUC of 0.98. Most of the dysregulated metabolites belonged to the pathways of fatty acid metabolism, lipid metabolism and nitric oxide metabolism. Validation of these metabolic signatures in large, diverse cohorts would pave way for the development of a robust test that can identify individuals at high risk of TB for targetted intervention of TB disease.Keywords
Funding Information
- Indian Council of Medical Research (5/8/5/45/Adhoc/2022/ECD-1)
- DST-INSPIRE
- NIH/DBT Indo-US Vaccine Action Programme
- Department of Biotechnology, Government of West Bengal
- Ministerio de Ciencia, Tecnología e Innovación
- Indian Council of Medical Research
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- Office of AIDS Research
This publication has 26 references indexed in Scilit:
- Predictive performance of interferon-gamma release assays and the tuberculin skin test for incident tuberculosis: an individual participant data meta-analysiseClinicalMedicine, 2023
- HMDB 5.0: the Human Metabolome Database for 2022Nucleic Acids Research, 2021
- MS2Compound: A User-Friendly Compound Identification Tool for LC-MS/MS-Based Metabolomics DataOMICS: A Journal of Integrative Biology, 2021
- Changes in Transcript, Metabolite, and Antibody Reactivity During the Early Protective Immune Response in Humans to Mycobacterium tuberculosis InfectionClinical Infectious Diseases, 2019
- Metabolite changes in blood predict the onset of tuberculosisNature Communications, 2018
- Global Epidemiology of TuberculosisSeminars in Respiratory and Critical Care Medicine, 2018
- Identification of specific metabolites in culture supernatant ofMycobacterium tuberculosisusing metabolomics: exploration of potential biomarkersEmerging Microbes & Infections, 2015
- Reference Interval Determination for Anabasine: A Biomarker of Active Tobacco UseJournal of Analytical Toxicology, 2014
- A cross-platform toolkit for mass spectrometry and proteomicsNature Biotechnology, 2012
- Spectrum of latent tuberculosis — existing tests cannot resolve the underlying phenotypesNature Reviews Microbiology, 2010